Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
17.68
-1.38 (-7.24%)
Feb 21, 2025, 4:00 PM EST - Market closed
Select Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 4,609 | 6,664 | 6,334 | 6,205 | 5,532 | Upgrade
|
| Revenue Growth (YoY) | -30.84% | 5.22% | 2.08% | 12.16% | 1.43% | Upgrade
|
| Cost of Revenue | 4,208 | 5,350 | 5,236 | 4,941 | 4,374 | Upgrade
|
| Gross Profit | 401.49 | 1,314 | 1,098 | 1,264 | 1,157 | Upgrade
|
| Selling, General & Admin | 153.04 | 552.53 | 517.23 | 491.12 | 474.09 | Upgrade
|
| Other Operating Expenses | -28.45 | -1.77 | -4.97 | -0.33 | - | Upgrade
|
| Operating Expenses | 256.74 | 759.51 | 718.09 | 693.43 | 679.75 | Upgrade
|
| Operating Income | 144.75 | 554.87 | 379.48 | 570.07 | 477.65 | Upgrade
|
| Interest Expense | -137.47 | -198.64 | -169.11 | -135.99 | -153.01 | Upgrade
|
| Interest & Investment Income | - | - | - | 5.35 | - | Upgrade
|
| Earnings From Equity Investments | 27.98 | 40.81 | 26.41 | 44.43 | 29.44 | Upgrade
|
| EBT Excluding Unusual Items | 35.27 | 397.05 | 236.78 | 483.87 | 354.07 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 2.16 | 12.39 | Upgrade
|
| Legal Settlements | - | - | - | 19.9 | - | Upgrade
|
| Other Unusual Items | - | -14.69 | 23.8 | 123.8 | 90.01 | Upgrade
|
| Pretax Income | 35.27 | 382.36 | 260.58 | 629.72 | 456.47 | Upgrade
|
| Income Tax Expense | 16.72 | 82.63 | 62.55 | 129.77 | 111.87 | Upgrade
|
| Earnings From Continuing Operations | 18.55 | 299.73 | 198.03 | 499.95 | 344.61 | Upgrade
|
| Earnings From Discontinued Operations | 179.48 | - | - | - | - | Upgrade
|
| Net Income to Company | 198.03 | 299.73 | 198.03 | 499.95 | 344.61 | Upgrade
|
| Minority Interest in Earnings | -39.03 | -56.24 | -39.03 | -97.72 | -85.61 | Upgrade
|
| Net Income | 158.99 | 243.49 | 158.99 | 402.23 | 259 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 8.77 | 5.61 | 13.44 | 8.9 | Upgrade
|
| Net Income to Common | 158.99 | 234.72 | 153.39 | 388.79 | 250.1 | Upgrade
|
| Net Income Growth | -34.70% | 53.14% | -60.47% | 55.30% | 74.47% | Upgrade
|
| Shares Outstanding (Basic) | 129 | 123 | 125 | 130 | 130 | Upgrade
|
| Shares Outstanding (Diluted) | 129 | 123 | 125 | 130 | 130 | Upgrade
|
| Shares Change (YoY) | 5.00% | -1.22% | -4.32% | 0.36% | -0.38% | Upgrade
|
| EPS (Basic) | 1.23 | 1.91 | 1.23 | 2.98 | 1.93 | Upgrade
|
| EPS (Diluted) | 1.23 | 1.91 | 1.23 | 2.98 | 1.93 | Upgrade
|
| EPS Growth | -35.49% | 54.92% | -58.77% | 54.89% | 75.01% | Upgrade
|
| Free Cash Flow | 94.45 | 352.86 | 94.45 | 220.69 | 881.63 | Upgrade
|
| Free Cash Flow Per Share | 0.73 | 2.87 | 0.76 | 1.69 | 6.79 | Upgrade
|
| Dividend Per Share | - | 0.500 | 0.500 | 0.500 | - | Upgrade
|
| Gross Margin | 8.71% | 19.72% | 17.33% | 20.36% | 20.92% | Upgrade
|
| Operating Margin | 3.14% | 8.33% | 5.99% | 9.19% | 8.63% | Upgrade
|
| Profit Margin | 3.45% | 3.52% | 2.42% | 6.27% | 4.52% | Upgrade
|
| Free Cash Flow Margin | 2.05% | 5.29% | 1.49% | 3.56% | 15.94% | Upgrade
|
| EBITDA | 350.58 | 763.62 | 585.31 | 772.72 | 683.3 | Upgrade
|
| EBITDA Margin | 7.61% | 11.46% | 9.24% | 12.45% | 12.35% | Upgrade
|
| D&A For EBITDA | 205.83 | 208.74 | 205.83 | 202.65 | 205.66 | Upgrade
|
| EBIT | 144.75 | 554.87 | 379.48 | 570.07 | 477.65 | Upgrade
|
| EBIT Margin | 3.14% | 8.33% | 5.99% | 9.19% | 8.63% | Upgrade
|
| Effective Tax Rate | 47.42% | 21.61% | 24.01% | 20.61% | 24.51% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.